Hepatitis C virus genotype 1 or 4
Drug research and approvals for hepatitis C virus genotype 1 or 4: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 22, 2026, 0 studies of hepatitis C virus genotype 1 or 4 are recruiting on ClinicalTrials.gov, and Health Canada has authorized 5 drug trials for it since 2013.
- Recruiting worldwide: 0
- Trials authorized in Canada: 5
- FDA orphan approvals: 0
- EU medicines: 0
| Oct 22, 2015 | An open-label, multicenter study to evaluate the pharmacokinetics, safety, and efficacy of ombitasvir (OBV), paritaprevir (PTV), ritonavir (RTV) with or…Paritaprevir (ABT-450)-ritonavir-ombitasvir (ABT-267)/ Dasabuvir (ABT-333)/… | AbbVie | Pending |
| Jul 10, 2015 | Open-label study to evaluate the safety and efficacy of the combination of ombitasvir, paritaprevir/r ± dasabuvir with ribavirin (RBV) in adult patients with…Paritaprevir (ABT-450)-ritonavir-ombitasvir (ABT-267)/ Dasabuvir (ABT-333)/… | AbbVie | Closed |
| Feb 14, 2014 | A phase 3, multicenter, open-label study to investigate the efficacy and safety of sofosbuvir/ledipasvir fixed-dose combination for 12 weeks in subjects with…Sofosbuvir-ledipasvir / Ribavirin | Gilead Sciences | Ongoing |
| Oct 9, 2013 | A phase 2, multicenter, open-label study to investigate the safety and efficacy of sofosbuvir/ledipasvir fixed-dose combination + ribavirin administered in…Sofosbuvir-ledipasvir/ Ribavirin | Gilead Sciences | Ongoing |
| Jun 14, 2013 | "a phase 3 open label study evaluating the efficacy and safety of pegylated interferon LAMBDA-1A, in combination with ribavirin and delatasvir, for treatment…BMS-914143/ Daclatasvir/ Ribavirin | Bristol-Myers Squibb | Ongoing |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA